INVESTIGATION OF THE EFFECT OF LATENT TOXOPLASMA GONDII INFECTION ON STRIATAL NEURODEGENERATION IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE

被引:0
|
作者
Jenkins, T. K. [1 ]
Donley, D. W. [2 ]
Fox, J. H. [2 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Wyoming, Laramie, WY 82071 USA
关键词
D O I
10.1136/jim-2017-000663.346
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
346
引用
收藏
页码:210 / 210
页数:1
相关论文
共 50 条
  • [1] Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
    Slow, EJ
    van Raamsdonk, J
    Rogers, D
    Coleman, SH
    Graham, RK
    Deng, Y
    Oh, R
    Bissada, N
    Hossain, SM
    Yang, YZ
    Li, XJ
    Simpson, EM
    Gutekunst, CA
    Leavitt, BR
    Hayden, MR
    HUMAN MOLECULAR GENETICS, 2003, 12 (13) : 1555 - 1567
  • [2] Oxidative metabolism in YAC128 mouse model of Huntington's disease
    Hamilton, James
    Pellman, Jessica J.
    Brustovetsky, Tatiana
    Harris, Robert A.
    Brustovetsky, Nickolay
    HUMAN MOLECULAR GENETICS, 2015, 24 (17) : 4862 - 4878
  • [3] Neuroinflammation in the YAC128 transgenic mouse model of Huntington's disease
    Connolly, C.
    Thiele, J.
    Beck, J.
    Lefroy, C.
    Hill, A.
    Leavitt, B. R.
    MOVEMENT DISORDERS, 2012, 27 : S58 - S58
  • [4] EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Miralles, Marta Garcia
    Tan, Liang Juin
    Lim, Madeline
    Geva, Michal
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A92
  • [5] Selective cognitive impairment in the YAC128 Huntington's disease mouse
    Brooks, Simon P.
    Janghra, Nari
    Higgs, Gemma V.
    Bayram-Weston, Zubeyde
    Heuer, Andreas
    Jones, Lesley
    Dunnett, Stephen B.
    BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 121 - 129
  • [6] Automated deformation analysis in the YAC128 Huntington disease mouse model
    Lerch, Jason P.
    Carroll, Jeffrey B.
    Spring, Shoshana
    Bertram, Lisa N.
    Schwab, Claudia
    Hayden, Michael R.
    Henkelman, R. Mark
    NEUROIMAGE, 2008, 39 (01) : 32 - 39
  • [7] Evaluation of pridopidine in the transgenic YAC128 mouse model of Huntington disease
    Garcia-Miralles, M.
    Yosuf, N. A. B. M.
    Tan, J. Y.
    Kusko, R.
    Tan, L. J.
    Xu, X.
    Orbach, A.
    Geva, M.
    Hayden, M. R.
    Pouladi, M. A.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 219 - 219
  • [8] Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease
    Van Raamsdonk, JM
    Pearson, J
    Bailey, CDC
    Rogers, DA
    Johnson, GVW
    Hayden, MR
    Leavitt, BR
    JOURNAL OF NEUROCHEMISTRY, 2005, 95 (01) : 210 - 220
  • [9] Anxiety, memory, and social impairments in the YAC128 mouse model of Huntington's disease
    Marinina, Ksenia S.
    Bezprozvanny, Ilya B.
    Egorova, Polina A.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (04) : 431 - 448
  • [10] TREATMENT WITH ARIMOCLOMOL DOES NOT LEAD TO RESCUE OF MOTOR OR STRIATAL DEFICITS IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Pouladi, M. A.
    Carroll, J.
    Santos, R. Dar
    Bertram, L.
    Hayden, M. R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A14 - A14